Avenir Wellness Solutions (AVRW)
OTHER OTC:AVRW
Top Page
No summary available
Positive Factors
Innovative Product Offerings
Avenir's focus on innovation in wellness products positions it to capture market share in the growing health-conscious consumer segment.
Negative Factors
Declining Revenue
Significant revenue decline indicates challenges in market demand or competitive positioning, impacting long-term financial health.
Read all positive and negative factors
Positive Factors
Negative Factors
Innovative Product Offerings
Avenir's focus on innovation in wellness products positions it to capture market share in the growing health-conscious consumer segment.
Read all positive factors
Avenir Wellness Solutions (AVRW) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$79.00
Dividend YieldN/A
Average Volume (3M)33.41K
Price to Earnings (P/E)―
Beta (1Y)23.83
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees11
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding78,925,170
10 Day Avg. Volume16,300
30 Day Avg. Volume33,406
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.54
Price to Sales (P/S)1.22
P/FCF Ratio-1.36
Enterprise Value/Market Cap104.43K
Enterprise Value/Revenue4.04
Enterprise Value/Gross Profit5.76
Enterprise Value/Ebitda-3.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Avenir Wellness Solutions Business Overview & Revenue Model
Company Description
Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products...
How the Company Makes Money
Avenir Wellness Solutions generates revenue primarily through the sale of its health supplements and personal care products. These products are distributed via both direct-to-consumer e-commerce platforms and partnerships with retail chains, provi...
Avenir Wellness Solutions Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.04M | 4.35M | 4.90M | 6.08M | 2.05M | 623.00K |
| Gross Profit | 1.43M | 3.11M | 3.34M | 4.33M | 975.00K | 392.00K |
| EBITDA | -2.54M | -3.20M | -16.45M | -5.53M | -27.22M | -16.64M |
| Net Income | -2.76M | -3.44M | -25.51M | -13.19M | -30.62M | -21.36M |
Balance Sheet | ||||||
| Total Assets | 748.00K | 2.61M | 6.85M | 40.57M | 46.36M | 32.46M |
| Cash, Cash Equivalents and Short-Term Investments | 11.00K | 49.00K | 2.94M | 16.00K | 1.73M | 4.10M |
| Total Debt | 8.86M | 8.28M | 10.06M | 13.87M | 16.33M | 790.00K |
| Total Liabilities | 13.30M | 12.49M | 13.96M | 24.46M | 25.08M | 16.13M |
| Stockholders Equity | -12.55M | -9.89M | -7.11M | 16.11M | 21.28M | 13.51M |
Cash Flow | ||||||
| Free Cash Flow | -1.55M | -3.90M | -10.07M | -4.43M | -10.41M | -8.51M |
| Operating Cash Flow | -1.54M | -3.84M | -10.07M | -4.32M | -9.72M | -8.10M |
| Investing Cash Flow | 1.25M | 971.00K | 13.84M | -175.00K | -131.00K | -917.00K |
| Financing Cash Flow | 121.00K | -22.00K | -837.00K | 2.78M | 7.48M | 12.61M |
Avenir Wellness Solutions Technical Analysis
Negative
0.01
Price Trends
0.01
Negative
0.02
Negative
0.02
Negative
Market Momentum
<0.01
Positive
42.00
Neutral
27.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVRW, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.01, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 42.00 is Neutral, neither overbought nor oversold. The STOCH value of 27.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVRW.
Avenir Wellness Solutions Risk Analysis
Avenir Wellness Solutions disclosed 54 risk factors in its most recent earnings report. Avenir Wellness Solutions reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Avenir Wellness Solutions Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| ― | $79.00 | ― | 21.97% | ― | ― | ― | |
72 Outperform | $1.06B | 4.20 | 13.51% | ― | 8.33% | 47.71% | |
63 Neutral | $1.49B | 5.80 | -36.19% | ― | -0.78% | 265.56% | |
61 Neutral | $428.41M | 19.90 | 12.18% | ― | 6.62% | -7.85% | |
53 Neutral | $317.83M | 33.56 | 2.03% | ― | 5.88% | -68.62% | |
46 Neutral | $5.69M | -1.06 | -74.59% | ― | ― | ― |
* Consumer Defensive Sector Average
AVRW
Avenir Wellness Solutions
0.01
-0.01
-50.00%
HLF
Herbalife
13.89
5.62
67.96%
NATR
Nature's Sunshine Products
24.25
12.47
105.86%
SENEA
Seneca Foods
160.92
74.53
86.27%
USNA
USANA Health
16.90
-8.58
-33.67%
HCWC
Healthy Choice Wellness Corp. Class A
0.24
-0.15
-37.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―